Synthesis and in vitro cytotoxicity of cis-(glycolato-O,O')-[2-substituted-(4R,5R)-4,5-bis(aminomethyl)-1,3-dioxolane] platinum(II)

Bioorganic and Medicinal Chemistry Letters

Volumn 6, Issue 7, 1996, Pages 771-774

  Kim, Dae Kee ^a   Gam, Jongsik ^a   Kim, Hun Taek ^a   Kim, Key H ^a  

^a Sunkyong Industries   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; CARBOPLATIN; CISPLATIN; EPTAPLATIN; PLATINUM COMPLEX; SKI 2034R; UNCLASSIFIED DRUG;

ARTICLE; CONTROLLED STUDY; CYTOTOXICITY; DRUG SYNTHESIS; HUMAN; HUMAN CELL; LUNG NON SMALL CELL CANCER; STOMACH CANCER; TUMOR CELL;

EID: 0029876141     PISSN: 0960894X     EISSN: None     Source Type: Journal    
DOI: 10.1016/0960-894X(96)00126-6     Document Type: Article

References (33)

1. Rosenberg, B.; VanCamp, L.; Trosko, J. E.; Mansour, V. H. Nature 1969, 222; 385.
2. (a) Carter, S. K. Platinum Coordination Complexes in Cancer Chemotherapy; Hacker, M. P., Douple, E. B., Krakoff, I. H., Eds.; Martinus Nijhoff Publishing: Boston, 1984; pp. 359;
3. (b) Durant, J. R. Cisplatin Current Status and New Developments; Prestayko, A. W., Crooke, S. T., Carter, S. K., Eds.; Academic Press, Inc.: New York, 1980; pp. 317;
4. (c) Loehrer, P. J.; Einhorn, L. H. Ann. Intern. Med. 1984, 100, 704;
5. (d) Einhorn, L. H.; Donohue, J. Ann. Intern. Med. 1977, 87, 293;
6. (e) Ozols, R. F.; Young, R. C. Semin. Oncol. 1984, 11, 251;
7. (f) Soloway, M. S. J. Urol. 1978, 120, 716;
8. (g) Choksi, A.; Hong, W. K. Platinum and Other Metal Coordination Complexes in Cancer Chemotherapy; Nicolini, M., Ed.; Martinus Nijhoff Publishing: Boston, 1988; pp. 375;
9. (h) Paccagnella, A.; Favaretto, G.; Fiorentino, M. V. In ref 2g, pp. 394;
10. (i) Wagener, D. J.; Yap, S. H.; Wobbes, T.; Burghouts, J. T.; van Dam, F. E.; Hillen, H. F.; Hoogendoorn, G. J.; Scheerder, H.; van der Vegt, S. G. Cancer Chemother. Pharmacol. 1985, 15, 86.
11. von Hoff, D. D.; Schilsky, R.; Reichert, C. M.; Reddick, R. L.; Rozencweig, M.; Young, R. C.; Muggia, F. M. Cancer Treat. Rep. 1979, 63, 1527.
12. (a) Kim, D.-K.; Gam, J.; Kim, K. H. Bioorg. Med. Chem. Lett. 1994, 4, 911;
13. (b) Carter, S. K.; Canetta, R.; Rozencweig, M. Cancer Treat. Rev. 1985, 12 (Suppl. A), 145;
14. (c) Akamatsu, K.; Endo, K.; Matsumoto, T.; Kamisango, K.; Morikawa, K.; Koizumi, M.; Koizumi, K. Br. J. Cancer 1992, 66, 827;
15. (d) Akaza, H.; Togashi, M.; Nishio, Y.; Miki, T.; Kotake, T.; Matsumura, Y.; Yoshida, O.; Aso, Y. Cancer Chemother. Pharmacol. 1992, 31, 187;
16. (e) Kraker, A. J.; Hoeschele, J. D.; Elliott, W. L.; Showalter, H. D. H.; Sercel, A. D. J. Med. Chem. 1992, 35, 4526;
17. (f) Mellish, K. J.; Kelland, L. R.; Harrap, K. R. Br. J. Cancer 1993, 68, 240.
18. Kim, D.-K.; Kim, G.; Gam, J.; Cho, Y.-B.; Kim, H.-T.; Tai, J.-H.; Kim, K. H.; Hong, W.-S.; Park, J.-G. J. Med. Chem. 1994, 37, 1471.
19. (a) Kim, D.-K. Drugs Future (in press);
20. (b) Cho, Y.-B.; Kim, D.-K.; Kim, K. H.; Miyamoto, G. Arzneim.-Forsch./Drug Res. (in press);
21. (c) Cho, Y.-B.; Kim, K. H.; Kim, D.-K.; Miyamoto, G. Arzneim.-Forsch./Drug Res. (in press);
22. (d) Kim, D.-K.; Kim, H.-T.; Tai, J. H.; Cho, Y.-B.; Kim, T.-S.; Kim, K. H.; Park, J.-G.; Hong, W.-S. Cancer Chemother. Pharmacol. 1995, 37, 1;
23. (e) Kim, D.-K.; Kim, H.-T.; Cho, Y.-B.; Tai, J. H.; Ahn, J. S.; Kim, T.-S.; Kim, K. H.; Hong, W.-S. Cancer Chemother. Pharmacol. 1995, 35, 441;
24. (f) Hong, W.-S.; Kim, H.-T.; Kim, K. H.; Kim, D.-K. Anticancer Res. 1995, 15, 51;
25. (g) Cho, Y.-B.; Kim, K. H.; Kim, D.-K. Drug Metab. Dispos. 1995, 23, 1280;
26. (h) Hong, W.-S.; Min, Y. I.; Kim, H.-T.; Cho, Y.-B.; Kim, K. H.; Kim, D.-K. J. Korean Med. Sci. 1995, 10, 269;
27. (i) Kim, D.-K.; Ahn, J. S.; Ryu, G.; Kim, K. H.; Park, C. W.; Kim, M. S.; Chung, M. H.; Shin, S. K.; Seo, Y. H.; Kim, Y. S.; Son, Y. S. Arzneim.-Forsch./Drug Res. 1994, 44(II), 1080;
28. (j) Kim, D.-K.; Kim, Y.; Rim, J.; Kim, G.; Gam, J.; Song, S.; Yoo, K.; Kim, K. H. J. Labelled Compd Radiopharm. 1994, 34, 157.
29. 5Pt: C, 28.89; H, 4.85; N, 6.12. Found: C, 29.02; H, 4.92; N, 5.87.
30. Miyamoto, T. K.; Okude, K.; Maeda, K.; Ichida, H.; Sasaki, Y.; Tashiro, T. Bull. Chem. Soc. Jpn. 1989, 62, 3239.
31. PC-9, PC-14, MKN-45, and KATO III were kindly provided by Professor W.-S. Hong, Asan Medical Center, College of Medicine, Ulsan University, Korea.
32. (a) Mosmann, T. J. Immunol. Methods 1983, 65, 55;
33. (b) Carmichael, J.; De Graff, W. G.; Gazdar, A. F.; Minna, J. D.; Mitchell, J. B. Cancer Res. 1987, 47, 936.